Entry |
|
Symbol |
JAK1
|
Name |
|
Pathway |
map01521 | EGFR tyrosine kinase inhibitor resistance |
map04550 | Signaling pathways regulating pluripotency of stem cells |
map04620 | Toll-like receptor signaling pathway |
map04621 | NOD-like receptor signaling pathway |
map04658 | Th1 and Th2 cell differentiation |
map05163 | Human cytomegalovirus infection |
map05166 | Human T-cell leukemia virus 1 infection |
map05167 | Kaposi sarcoma-associated herpesvirus infection |
map05168 | Herpes simplex virus 1 infection |
map05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Disease |
H02537 | Autoinflammation, immune dysregulation, and eosinophilia |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09130 Environmental Information Processing
09132 Signal transduction
04630 JAK-STAT signaling pathway
K11217 JAK1; Janus kinase 1
04151 PI3K-Akt signaling pathway
K11217 JAK1; Janus kinase 1
09140 Cellular Processes
09143 Cell growth and death
04217 Necroptosis
K11217 JAK1; Janus kinase 1
09144 Cellular community - eukaryotes
04550 Signaling pathways regulating pluripotency of stem cells
K11217 JAK1; Janus kinase 1
09150 Organismal Systems
09151 Immune system
04620 Toll-like receptor signaling pathway
K11217 JAK1; Janus kinase 1
04621 NOD-like receptor signaling pathway
K11217 JAK1; Janus kinase 1
04658 Th1 and Th2 cell differentiation
K11217 JAK1; Janus kinase 1
04659 Th17 cell differentiation
K11217 JAK1; Janus kinase 1
09158 Development and regeneration
04380 Osteoclast differentiation
K11217 JAK1; Janus kinase 1
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
K11217 JAK1; Janus kinase 1
05203 Viral carcinogenesis
K11217 JAK1; Janus kinase 1
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
K11217 JAK1; Janus kinase 1
09162 Cancer: specific types
05212 Pancreatic cancer
K11217 JAK1; Janus kinase 1
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
K11217 JAK1; Janus kinase 1
05161 Hepatitis B
K11217 JAK1; Janus kinase 1
05160 Hepatitis C
K11217 JAK1; Janus kinase 1
05171 Coronavirus disease - COVID-19
K11217 JAK1; Janus kinase 1
05164 Influenza A
K11217 JAK1; Janus kinase 1
05162 Measles
K11217 JAK1; Janus kinase 1
05168 Herpes simplex virus 1 infection
K11217 JAK1; Janus kinase 1
05163 Human cytomegalovirus infection
K11217 JAK1; Janus kinase 1
05167 Kaposi sarcoma-associated herpesvirus infection
K11217 JAK1; Janus kinase 1
05169 Epstein-Barr virus infection
K11217 JAK1; Janus kinase 1
05165 Human papillomavirus infection
K11217 JAK1; Janus kinase 1
09171 Infectious disease: bacterial
05152 Tuberculosis
K11217 JAK1; Janus kinase 1
09174 Infectious disease: parasitic
05145 Toxoplasmosis
K11217 JAK1; Janus kinase 1
05140 Leishmaniasis
K11217 JAK1; Janus kinase 1
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
K11217 JAK1; Janus kinase 1
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases
K11217 JAK1; Janus kinase 1
Enzymes [BR:ko01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.10 Protein-tyrosine kinases
2.7.10.2 non-specific protein-tyrosine kinase
K11217 JAK1; Janus kinase 1
Protein kinases [BR:ko01001]
Non-receptor tyrosine kinases
JAK family [OT]
K11217 JAK1; Janus kinase 1
|
Other DBs |
|
Genes |
» show all
|
Reference |
|
Authors |
Wilks AF, Harpur AG, Kurban RR, Ralph SJ, Zurcher G, Ziemiecki A |
Title |
Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. |
Journal |
|
Sequence |
|